About Dendreon
Dendreon is a company based in Seal Beach (United States) founded in 1992 was acquired by Nanjing Xinbai in May 2018. It operates as a HealthTech, and Professional Services. Dendreon has raised $21.7 million across 3 funding rounds from investors including New York Life Insurance, Nanjing Xinbai and Healthcare Ventures. Dendreon offers products and services including Provenge and Cellular Therapy Manufacturing. Dendreon operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Seal Beach, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Dendreon Pharmaceuticals Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$21.7 M (USD)
in 3 rounds
-
Latest Funding Round
$10 M (USD), Series C
Oct 22, 1999
-
Investors
New York Life Insurance
& 6 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dendreon
Dendreon offers a comprehensive portfolio of products and services, including Provenge and Cellular Therapy Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provenge is used for advanced prostate cancer treatment.
Manufacturing support is provided for cellular therapy development.
Unlock access to complete
Software Development Team
28 people
Operations Team
20 people
Sales and Marketing
8 people
Leadership Team
5 people
Corporate Team
5 people
Finance and Accounting
5 people
Senior Team
4 people
Human Resources and Administration
4 people
Unlock access to complete
Funding Insights of Dendreon
Dendreon has successfully raised a total of $21.7M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $10 million completed in October 1999. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $10.0M
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 1999 | Amount | Series C - Dendreon | Valuation |
investors |
|
| Sep, 1997 | Amount | Series B - Dendreon | Valuation |
investors |
|
| Jun, 1996 | Amount | Series A - Dendreon | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Dendreon
Dendreon has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include New York Life Insurance, Nanjing Xinbai and Healthcare Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Biomedical investment financing and active management services.
|
Founded Year | Domain | Location | |
|
Private equity investments are backed by a single-family office firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Dendreon
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Dendreon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dendreon Comparisons
Competitors of Dendreon
Dendreon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dendreon
Frequently Asked Questions about Dendreon
When was Dendreon founded?
Dendreon was founded in 1992 and raised its 1st funding round 4 years after it was founded.
Where is Dendreon located?
Dendreon is headquartered in Seal Beach, United States. It is registered at Seal Beach, California, United States.
Is Dendreon a funded company?
Dendreon is a funded company, having raised a total of $21.7M across 3 funding rounds to date.
What does Dendreon do?
Dendreon is engaged in the development and delivery of cellular therapies and immunotherapies aimed at improving patient outcomes. The company operates within the healthcare sector, specializing in biotechnology with a focus on innovative treatments like Provenge, an FDA-approved immunotherapy for prostate cancer. Strategic partnerships and research are leveraged to advance complex cell therapies. Manufacturing services are also provided to support other companies in bringing life-saving innovations to market.
Who are the top competitors of Dendreon?
Dendreon's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Dendreon offer?
Dendreon offers Provenge and Cellular Therapy Manufacturing.
Who are Dendreon's investors?
Dendreon has 7 investors. Key investors include New York Life Insurance, Nanjing Xinbai, Healthcare Ventures, Sanderling Ventures, and Vulcan Capital.